Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Intangibles (2018 - 2025)

China SXT Pharmaceuticals (SXTC) has 7 years of Intangibles data on record, last reported at $19101.0 in Q1 2024.

  • For Q1 2024, Intangibles fell 75.86% year-over-year to $19101.0; the TTM value through Mar 2024 reached $19101.0, down 75.86%, while the annual FY2024 figure was $19101.0, 75.86% down from the prior year.
  • Intangibles reached $19101.0 in Q1 2024 per SXTC's latest filing, down from $79134.0 in the prior quarter.
  • Across five years, Intangibles topped out at $85728.0 in Q1 2022 and bottomed at $19101.0 in Q1 2024.
  • Average Intangibles over 5 years is $55963.0, with a median of $50052.0 recorded in 2020.
  • Peak YoY movement for Intangibles: skyrocketed 87.18% in 2022, then tumbled 75.86% in 2024.
  • A 5-year view of Intangibles shows it stood at $50052.0 in 2020, then fell by 8.5% to $45800.0 in 2021, then surged by 87.18% to $85728.0 in 2022, then decreased by 7.69% to $79134.0 in 2023, then crashed by 75.86% to $19101.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Intangibles were $19101.0 in Q1 2024, $79134.0 in Q1 2023, and $85728.0 in Q1 2022.